TGFB1 and neuroblastoma: Similarly to other cancers, neuroblastoma has evolved immune evasion strategies such as downregulation of MHC class-1 expression, increased activity of immune inhibitor factors such as TGFβ and arginase-2, and enhanced infiltration of suppressive myeloid cells [31,96,97,98].